Please assess the completion status of the following clinical trial:

Trial Title: Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* male~* age \>18~* biopsy-proven non-small cell lung cancer~* surgical intervention planned~Exclusion Criteria:~* current use of 5-alpha reductase inhibitor~* previous diagnosis of prostate cancer~* previous hypersensitivity to 5-alpha reductase inhibitor

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- finasteride (Type: EXPERIMENTAL): finasteride 5mg po od from study entry to date of surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).